{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:47:33Z","timestamp":1782996453441,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neurol.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T11:54:40Z","timestamp":1728302080000},"page":"79-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Congenital myasthenic syndromes by Epsilon subunit mutations: Phenotypic profiles of 17 Algerian families"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2656-8716","authenticated-orcid":false,"given":"M.I.","family":"Kediha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Eymard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ali Pacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2024.09.007_bib0140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2024.09.007_bib0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13023-019-1025-5","article-title":"Congenital myasthenic syndromes","volume":"14","author":"Finsterer","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.neurol.2024.09.007_bib0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0037-1602832","article-title":"The increasing genetic and phenotypical diversity of congenital myasthenic syndromes","volume":"48","author":"McMacken","year":"2017","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.neurol.2024.09.007_bib0155","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1212\/WNL.53.7.1564","article-title":"A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin","volume":"53","author":"Abicht","year":"1999","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.neurol.2024.09.007_bib0160","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.wnl.0000336921.51639.0b","article-title":"The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa","volume":"71","author":"Richard","year":"2008","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2024.09.007_bib0165","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.nmd.2019.10.010","article-title":"The 2020 version of the gene table of monogenic neuromuscular disorders (nuclear genome only)","volume":"29","author":"Benarroch","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.neurol.2024.09.007_bib0170","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1073\/pnas.92.3.758","article-title":"Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit","volume":"92","author":"Ohno","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.neurol.2024.09.007_bib0175","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.410390607","article-title":"A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome","volume":"39","author":"Gomez","year":"1996","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2024.09.007_bib0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0896-6273(00)80289-5","article-title":"Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit","volume":"17","author":"Ohno","year":"1996","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.neurol.2024.09.007_bib0185","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/hmg\/5.9.1217","article-title":"New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome","volume":"5","author":"Engel","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.neurol.2024.09.007_bib0190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s004150050585","article-title":"Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis","volume":"247","author":"Sharshar","year":"2000","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2024.09.007_bib0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ncl.2018.01.006","article-title":"Measuring clinical treatment response in myasthenia gravis","volume":"36","author":"Barnett","year":"2018","journal-title":"Neurol Clin"},{"issue":"12","key":"10.1016\/j.neurol.2024.09.007_bib0200","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nmd.2017.08.003","article-title":"Molecular characterization of congenital myasthenic syndromes in Spain","volume":"27","author":"Natera-de Benito","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2024.09.007_bib0205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/B978-0-444-64076-5.00037-5","article-title":"Genetic basis and phenotypic features of congenital myasthenic syndromes","volume":"148","author":"Engel","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2024.09.007_bib0210","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00415-009-5190-7","article-title":"AChR deficiency due to epsilon-subunit mutations: two common mutations in the Netherlands","volume":"256","author":"Faber","year":"2009","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2024.09.007_bib0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.22153","article-title":"Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations","volume":"44","author":"Sadeh","year":"2011","journal-title":"Muscle Nerve"},{"issue":"Suppl. 2","key":"10.1016\/j.neurol.2024.09.007_bib0220","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.3233\/JND-150098","article-title":"Congenital myasthenic syndromes with predominant limb girdle weakness","volume":"2","author":"Evangelista","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"5","key":"10.1016\/j.neurol.2024.09.007_bib0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1212\/WNL.0b013e31825b5bda","article-title":"Highly fatal fast-channel syndrome caused by AChR \u025b subunit mutation at the agonist binding site","volume":"79","author":"Shen","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neurol.2024.09.007_bib0230","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1212\/WNL.0000000000001952","article-title":"Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes","volume":"85","author":"Rodr\u00edguez Cruz","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neurol.2024.09.007_bib0235","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.arcped.2015.04.009","article-title":"Syndromes myasth\u00e9niques cong\u00e9nitaux de l\u2019enfant\u00a0: strat\u00e9gies th\u00e9rapeutiques m\u00e9dicamenteuses [Congenital myasthenic syndromes in childhood: Drug therapeutic strategies]","volume":"22","author":"de la Vaissi\u00e8re","year":"2015","journal-title":"Arch Pediatr"},{"issue":"1","key":"10.1016\/j.neurol.2024.09.007_bib0240","first-page":"28","article-title":"Congenital myasthenic syndrome: phenotypic variability in patients harbouring p.T159P mutation in\u00a0CHRNE\u00a0gene","volume":"36","author":"Ardissone","year":"2017","journal-title":"Acta Myol"},{"issue":"2","key":"10.1016\/j.neurol.2024.09.007_bib0245","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mus.22153","article-title":"Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations","volume":"44","author":"Sadeh","year":"2011","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.neurol.2024.09.007_bib0250","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nmd.2011.08.002","article-title":"Clinical features in a series of fast channel congenital myasthenia syndrome","volume":"22","author":"Palace","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.neurol.2024.09.007_bib0255","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00424-005-1387-5","article-title":"Mutation of single murine acetylcholine receptor subunits reveals differential contribution of P121 to acetylcholine binding and channel opening","volume":"450","author":"Peter","year":"2005","journal-title":"Pflugers Arch"},{"issue":"2","key":"10.1016\/j.neurol.2024.09.007_bib0260","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/jaut.1996.0021","article-title":"Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects","volume":"9","author":"Heckmann","year":"1996","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.neurol.2024.09.007_bib0265","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.gene.6364041","article-title":"Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis","volume":"5","author":"Giraud","year":"2004","journal-title":"Genes Immun"},{"issue":"12","key":"10.1016\/j.neurol.2024.09.007_bib0270","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.nmd.2015.08.001","article-title":"Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis","volume":"25","author":"Santos","year":"2015","journal-title":"Neuromuscul Disord"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872400599X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872400599X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T19:33:33Z","timestamp":1737574413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537872400599X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S003537872400599X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2024.09.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Congenital myasthenic syndromes by Epsilon subunit mutations: Phenotypic profiles of 17 Algerian families","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}